Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein (Q73284545)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1996

Language	Label	Description	Also known as
English	Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein	scientific article published on 01 December 1996

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Guido Franceschini

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Marja-Riitta Taskinen

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M Syvänne

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Castro

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Dengremont

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C De Geitere

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Jauhiainen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Ehnholm

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Michelagnoli

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Kahri

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

127

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

245-253

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Reverse cholesterol transport: physiology and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

High-density lipoprotein--the clinical implications of recent studies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Hyperlipidaemia in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Apolipoprotein A-I-containing particles and reverse cholesterol transport in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Insulin excess counteracts the effects of HDL on intracellular sterol accumulation in cultured human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Cross-linking of apolipoproteins is involved in a loss of the ligand activity of high density lipoprotein upon Cu(2+)-mediated oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Reduced cholesterol efflux to mildly oxidized high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Cholesterol efflux from human monocyte-derived macrophages in the presence of LpA-I:A-II

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratios

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I: A-II and LpA-IV particles from plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Effects of interactions of apolipoprotein A-II with apolipoproteins A-I or A-IV on [3H]cholesterol efflux and uptake in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Variations in the apolipoprotein AI-CIII-AIV gene region and in lecithin:cholesterol acyltransferase concentration are determinants of plasma cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Effect of LCAT on HDL-mediated cholesterol efflux from loaded EA.hy 926 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905962-X

7 January 2021

Identifiers

10.1016/S0021-9150(96)05962-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9125315%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73284545&oldid=1754706488"